Total Payments
$10,978
2024 Payments
$1,352
Companies
48
Transactions
398
Medicare Patients
16,676
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$9,237 (84.1%)
Travel$1,508 (13.7%)
Education$232.99 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,237 | 389 | 84.1% |
| Travel and Lodging | $1,508 | 6 | 13.7% |
| Education | $232.99 | 3 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,907 | 123 | $0 (2024) |
| PALETTE LIFE SCIENCES, INC. | $1,775 | 8 | $0 (2023) |
| Boston Scientific Corporation | $1,425 | 33 | $0 (2024) |
| ABBVIE INC. | $950.18 | 57 | $0 (2024) |
| Medtronic USA, Inc. | $771.18 | 8 | $0 (2017) |
| PFIZER INC. | $594.42 | 34 | $0 (2024) |
| Medtronic, Inc. | $321.37 | 15 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $284.85 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $232.99 | 12 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $171.40 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,352 | 72 | ABBVIE INC. ($257.45) |
| 2023 | $3,102 | 72 | PALETTE LIFE SCIENCES, INC. ($1,350) |
| 2022 | $1,800 | 59 | BOSTON SCIENTIFIC CORPORATION ($504.33) |
| 2021 | $1,084 | 56 | Astellas Pharma US Inc ($368.36) |
| 2020 | $625.96 | 34 | Astellas Pharma US Inc ($216.77) |
| 2019 | $646.93 | 38 | Astellas Pharma US Inc ($300.74) |
| 2018 | $1,121 | 44 | Astellas Pharma US Inc ($306.46) |
| 2017 | $1,247 | 23 | Medtronic USA, Inc. ($771.18) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $21.04 | General |
| Category: Prostate cancer | ||||||
| 10/30/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $78.27 | General |
| Category: AMS 700_URO | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/24/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/23/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $22.12 | General |
| Category: Prostate cancer | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: rezum_URO | ||||||
| 09/19/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/11/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Prostate cancer | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: HORMONE THERAPY | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Oncology | ||||||
| 08/22/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 4,517 | 8,236 | $418,274 | $325,309 |
| 2022 | 39 | 4,471 | 8,073 | $436,363 | $338,727 |
| 2021 | 39 | 4,392 | 8,015 | $423,024 | $333,219 |
| 2020 | 40 | 3,296 | 5,169 | $240,406 | $175,447 |
Total Patients
16,676
Total Services
29,493
Medicare Billing
$1.2M
Procedure Codes
151
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 826 | 1,221 | $149,488 | $99,100 | 66.3% |
| 87799 | Detection test by nucleic acid for organism, quantification | Office | 2023 | 189 | 915 | $39,199 | $38,415 | 98.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 23 | 195 | $36,969 | $25,456 | 68.9% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 195 | 704 | $24,703 | $24,210 | 98.0% |
| 87482 | Detection test for candida species (yeast), quantification | Office | 2023 | 189 | 304 | $16,945 | $16,608 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 143 | 143 | $23,040 | $15,985 | 69.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 65 | 76 | $17,464 | $12,554 | 71.9% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 195 | 337 | $11,825 | $11,589 | 98.0% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 195 | 316 | $11,088 | $10,867 | 98.0% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 189 | 305 | $10,702 | $10,489 | 98.0% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 189 | 304 | $10,667 | $10,455 | 98.0% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 12 | 12 | $13,092 | $8,410 | 64.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 64 | 154 | $8,195 | $6,029 | 73.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 232 | 294 | $5,407 | $5,298 | 98.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 11 | 11 | $6,460 | $4,373 | 67.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 12 | $4,761 | $3,557 | 74.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 812 | 1,306 | $3,155 | $2,862 | 90.7% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 85 | 242 | $3,503 | $2,537 | 72.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 268 | 373 | $3,642 | $2,517 | 69.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 25 | 49 | $3,310 | $2,411 | 72.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 53 | 92 | $2,375 | $2,327 | 98.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 39 | 45 | $3,239 | $2,321 | 71.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 27 | 74 | $2,441 | $1,581 | 64.8% |
| 87184 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | Office | 2023 | 102 | 164 | $1,227 | $1,202 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 122 | $1,643 | $1,144 | 69.6% |
About Dr. Aaron Benham, MD
Dr. Aaron Benham, MD is a Urology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1174884886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Benham, MD has received a total of $10,978 in payments from pharmaceutical and medical device companies, with $1,352 received in 2024. These payments were reported across 398 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($9,237).
As a Medicare-enrolled provider, Benham has provided services to 16,676 Medicare beneficiaries, totaling 29,493 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Oklahoma City, OK
- Active Since 05/30/2012
- Last Updated 07/21/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1174884886
Products in Payments
- XTANDI (Drug) $1,114
- INTERSTIM (Device) $1,093
- LUPRON DEPOT (Drug) $794.70
- MYRBETRIQ (Drug) $428.04
- Myrbetriq (Drug) $354.82
- AMS 700 CXR RTE Kit (Device) $321.24
- ERLEADA (Drug) $207.85
- AMS 700 (Device) $203.76
- ORGOVYX (Drug) $196.35
- AQUABEAM ROBOTIC SYSTEM (Device) $171.40
- Xtandi (Drug) $169.32
- Erleada (Drug) $167.85
- Axonics r-SNM System (Device) $155.26
- Da Vinci Surgical System (Device) $149.72
- General - Male SUI (Device) $148.19
- UroLift (Device) $147.91
- Rezum (Device) $143.00
- Olympus Cysto-Resection (Device) $136.32
- Uterine Manipulators & Injectors (Device) $125.00
- AMS 700 CXR RTE KIT (Device) $124.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Oklahoma City
Dr. Mohammad Ramadan, Md, MD
Urology — Payments: $158,035
Urology $158,035
Michael Cookson, Md, MD
Urology — Payments: $142,018
Urology $142,018
Basel Hassoun, Md, MD
Urology — Payments: $124,197
Urology $124,197
Dr. Kelly Stratton, Md, MD
Urology — Payments: $79,009
Urology $79,009
Dr. Ashley Bowen, M.d.,M.b.a, M.D.,M.B.A
Urology — Payments: $33,045
Urology $33,045
Sardar Mohammad Khan Galzie, Md, MD
Urology — Payments: $23,330
Urology $23,330